Treating eczema could also alleviate asthma

January 19, 2018, VIB (the Flanders Institute for Biotechnology)

Scientists from VIB-UGent have discovered insights for a possible new therapy for eczema that also reduces the severity of asthma. The findings are an important next step in understanding the relationship between the two inflammatory diseases and to developing effective therapies. The results of the study are published in the Journal of Investigative Dermatology.

Children with (AD), a type of eczema of the skin, show an increased risk of developing asthma later in life. This phenomenon, also known as atopic march, raises questions on whether therapies can be developed that not only tackle AD, but also prevent the onset of other . Intrigued by this possibility, a team of VIB scientists took to the lab.

Marching from the skin to the lungs

House dust mites are known culprits in the development of both AD and asthma, as exposure to the mites induces inflammation. Dr. Julie Deckers, Prof. Karolien De Bosscher and Prof. Hamida Hammad (all VIB-UGent Center for Inflammation Research) created a mouse model to look further into the relationship between the two diseases.

Dr. Julie Deckers (VIB-UGent): "As predicted, our test showed that house dust mite-induced skin inflammation leads to aggravated levels of allergic airway inflammation. Yet, to our surprise, this response significantly differs from the reaction to direct exposure of house dust mites in the lungs without prior skin inflammation. These results have given us a deeper understanding of the complexity of the atopic march."

One therapy to rule them all

The real challenge, however, was to investigate whether the relief of skin might influence the subsequent development of asthma. The team therefore combined two anti-inflammatory compounds – corticosteroids and PPARƴ agonists – into one potential treatment in mice.

Dr. Julie Deckers (VIB-UGent Center for Inflammation Research): "The combined therapy effectively alleviated AD, but was insufficient at preventing allergic asthmatic response in the lungs. However, the treatment did significantly reduce the severity of the asthma by counteracting one aspect of the in the lungs. In this way, the therapy represents a potent remedy against allergic and the aggravation of atopic march."

The team is now looking for industrial partners to develop clinical trials for the , making the leap from mouse to man. At the same time, they plan to further investigate the exact mechanisms driving the progression from AD to in order to develop alternative therapies that can halt the atopic march.

Explore further: Researchers discover key driver of atopic dermatitis

More information: Julie Deckers et al. Co-activation of GR and PPARγ in murine skin prevents worsening of atopic march, Journal of Investigative Dermatology (2017). DOI: 10.1016/j.jid.2017.12.023

Related Stories

Researchers discover key driver of atopic dermatitis

January 17, 2018
Severe eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that is driven by an allergic reaction. In their latest study, researchers at La Jolla Institute reveal an important player that promotes ...

Research reveals possible new treatment pathway for severe allergic asthma

October 13, 2017
Research demonstrates that blocking the action of two pro-inflammatory molecules significantly reduces symptoms of allergic asthma in mice, which could lead to development of a new treatment for people with a severe form ...

How the skin becomes inflamed

November 8, 2017
Publishing online this week in Cell Host & Microbe, researchers at Johns Hopkins report the discovery of a key underlying immune mechanism that explains why to how our skin becomes inflamed from conditions such as atopic ...

Scientists unearth cell 'checkpoint' that stops allergic diseases

August 9, 2017
Scientists from Trinity College Dublin have made a significant breakthrough in understanding the regulation of immune cells that play a pivotal role in allergic diseases such as asthma and eczema. They have identified a 'checkpoint' ...

Reason why farm kids develop fewer allergies explained

December 7, 2016
Scientists have discovered why growing up on a farm might protect children from developing allergies. Using studies in both mice and humans, they found that exposure to farm dust increases expression of a protective protein ...

Countering atopic dermatitis immune reactions

August 4, 2017
Human leukocyte antigen (HLA)-G is a protein that interacts with specific cell receptors to inhibit immune responses. The protein is best known for its role in protecting the fetus from attack by its mother's immune system. ...

Recommended for you

Obesity and health problems: New research on a safeguard mechanism

March 16, 2018
Obesity and its negative impacts on health - including metabolic syndrome, type-2 diabetes mellitus and cardiovascular complications - are a global pandemic (Taubes, 2009). The worldwide incidence of obesity has more than ...

Immune system 'double agent' could be new ally in cancer fight

March 16, 2018
St. Jude Children's Research Hospital scientists have discovered that an enzyme called TAK1 functions like a "double agent" in the innate immune response, serving as an unexpected regulator of inflammation and cell death. ...

Artificial sweetener Splenda could intensify symptoms in those with Crohn's disease

March 15, 2018
In a study that has implications for humans with inflammatory diseases, researchers from Case Western Reserve University School of Medicine and colleagues have found that, given over a six-week period, the artificial sweetener ...

Researchers identify common biological features of different types of asthma

March 14, 2018
A team of researchers from the NIHR Leicester Biomedical Research Centre - a partnership between Leicester's Hospitals, the University of Leicester and Loughborough University - has identified biological variations in lung ...

Scientists discover treatment target for sepsis

March 14, 2018
In a study published in Nature Communications, Northwestern Medicine scientists demonstrated the key role a molecule called oxPAPC plays in regulating the inflammatory response—findings which could inform the development ...

Researcher creates 'Instagram' of immune system, blending science, technology

March 10, 2018
Being on the cutting edge of science and technology excites Hollings Cancer Center (HCC) researcher Carsten Krieg, Ph.D. Each day, he walks into his lab that houses a mass cytometry machine aptly labeled Helios. Krieg explains ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.